FibroGen (FGEN) Insider Trading & Ownership → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free fgen Stock Alerts $1.04 +0.02 (+1.96%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability FibroGen (NASDAQ:FGEN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.39%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$95,500.00Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$664,445.76 Get FGEN Insider Trade Alerts Want to know when executives and insiders are buying or selling FibroGen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FGEN Insider Buying and Selling by Quarter Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. FibroGen Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2024Thane WettigCEOBuy50,000$1.91$95,500.00 9/1/2023Jeffrey William HendersonDirectorSell2,000$1.03$2,060.00 8/4/2023Jeffrey William HendersonDirectorSell2,000$1.91$3,820.00 7/11/2023Jeffrey William HendersonDirectorSell2,000$2.69$5,380.00 7/7/2023Enrique A ConternoCEOSell1,880$2.80$5,264.00 6/23/2023Thane WettigInsiderSell791$16.53$13,075.23 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/13/2023Christine ChungSVPSell6,250$17.60$110,000.00 6/9/2023Benjamin CravattDirectorSell3,944$17.17$67,718.48 6/7/2023Christine ChungSVPSell3,633$17.04$61,906.32 6/7/2023Enrique A ConternoCEOSell8,897$17.04$151,604.88 6/7/2023James A SchoeneckDirectorSell7,100$18.03$128,013.00 6/7/2023Juan GrahamCFOSell1,785$16.99$30,327.15 6/7/2023Mark EisnerEVPSell2,042$17.04$34,795.68 6/7/2023Thane WettigInsiderSell1,758$17.04$29,956.32 6/2/2023Mark EisnerEVPSell1,090$18.83$20,524.70 (Data available from 1/1/2013 forward) FGEN Insider Trading Activity - Frequently Asked Questions Who is on FibroGen's Insider Roster? The list of insiders at FibroGen includes Benjamin Cravatt, Christine Chung, Enrique A Conterno, James A Schoeneck, Jeffrey William Henderson, Juan Graham, Mark Eisner, Pat Cotroneo, Thane Wettig, and Thomas F Kearns Jr. Learn more on insiders at FGEN. What percentage of FibroGen stock is owned by insiders? 2.39% of FibroGen stock is owned by insiders. Learn more on FGEN's insider holdings. Which FibroGen insiders have been buying company stock? The following insider purchased FGEN shares in the last 24 months: Thane Wettig ($95,500.00). How much insider buying is happening at FibroGen? Insiders have purchased a total of 50,000 FGEN shares in the last 24 months for a total of $95,500.00 bought. Which FibroGen insiders have been selling company stock? The following insiders have sold FGEN shares in the last 24 months: Benjamin Cravatt ($67,718.48), Christine Chung ($643,384.20), Enrique A Conterno ($1,424,346.15), James A Schoeneck ($128,013.00), Jeffrey William Henderson ($11,260.00), Juan Graham ($219,756.79), Mark Eisner ($588,387.42), and Thane Wettig ($77,593.08). How much insider selling is happening at FibroGen? Insiders have sold a total of 169,582 FibroGen shares in the last 24 months for a total of $3,160,459.12 sold. More Insider Trading Tools from MarketBeat Related Companies: Karyopharm Therapeutics Insider Trading CytomX Therapeutics Insider Trading Vistagen Therapeutics Insider Trading Nuvectis Pharma Insider Trading Repare Therapeutics Insider Trading Sagimet Biosciences Insider Trading OptiNose Insider Trading Rezolute Insider Trading Amylyx Pharmaceuticals Insider Trading Relmada Therapeutics Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:FGEN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.